Cardinal Health Inc (NYSE:CAH) – Equities research analysts at William Blair dropped their FY2018 earnings estimates for Cardinal Health in a report issued on Tuesday. William Blair analyst J. Kreger now anticipates that the company will post earnings of $5.24 per share for the year, down from their previous estimate of $6.01. William Blair has a “Market Perform” rating on the stock. William Blair also issued estimates for Cardinal Health’s FY2019 earnings at $5.71 EPS and FY2020 earnings at $6.30 EPS.
Other research analysts also recently issued research reports about the company. Zacks Investment Research downgraded Cardinal Health from a “hold” rating to a “sell” rating in a report on Friday, February 10th. Leerink Swann set a $72.00 target price on Cardinal Health and gave the stock a “hold” rating in a report on Friday. Evercore ISI raised Cardinal Health to an “outperform” rating in a report on Thursday, April 6th. Needham & Company LLC assumed coverage on Cardinal Health in a report on Tuesday, April 4th. They set a “hold” rating on the stock. Finally, Vetr downgraded Cardinal Health from a “buy” rating to a “hold” rating and set a $76.99 target price on the stock. in a report on Tuesday, January 3rd. Two equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and five have assigned a buy rating to the company’s stock. Cardinal Health presently has a consensus rating of “Hold” and a consensus price target of $85.73.
Cardinal Health (NYSE:CAH) traded down 1.40% during trading on Friday, reaching $72.28. The company’s stock had a trading volume of 1,983,696 shares. The company has a market capitalization of $22.80 billion, a P/E ratio of 17.40 and a beta of 0.71. The company’s 50-day moving average is $81.14 and its 200-day moving average is $75.87. Cardinal Health has a 1-year low of $62.70 and a 1-year high of $87.33.
Cardinal Health (NYSE:CAH) last released its earnings results on Tuesday, February 7th. The company reported $1.34 earnings per share for the quarter, beating the consensus estimate of $1.23 by $0.11. The company earned $33.10 billion during the quarter, compared to the consensus estimate of $33.63 billion. Cardinal Health had a return on equity of 25.52% and a net margin of 1.06%. Cardinal Health’s revenue was up 5.4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.30 EPS.
The firm also recently announced a quarterly dividend, which was paid on Saturday, April 15th. Investors of record on Monday, April 3rd were given a $0.4489 dividend. This represents a $1.80 annualized dividend and a yield of 2.45%. The ex-dividend date of this dividend was Thursday, March 30th. Cardinal Health’s dividend payout ratio is currently 43.17%.
In related news, Chairman George S. Barrett sold 217,994 shares of the firm’s stock in a transaction that occurred on Friday, February 10th. The stock was sold at an average price of $77.23, for a total value of $16,835,676.62. Following the sale, the chairman now directly owns 682,225 shares in the company, valued at approximately $52,688,236.75. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.94% of the stock is owned by company insiders.
A number of hedge funds have recently bought and sold shares of CAH. Great West Life Assurance Co. Can boosted its stake in Cardinal Health by 0.8% in the third quarter. Great West Life Assurance Co. Can now owns 713,685 shares of the company’s stock valued at $55,466,000 after buying an additional 5,743 shares in the last quarter. GHP Investment Advisors Inc. boosted its stake in Cardinal Health by 3.3% in the third quarter. GHP Investment Advisors Inc. now owns 16,422 shares of the company’s stock valued at $1,276,000 after buying an additional 519 shares in the last quarter. River Road Asset Management LLC boosted its stake in Cardinal Health by 50.5% in the third quarter. River Road Asset Management LLC now owns 673,277 shares of the company’s stock valued at $52,314,000 after buying an additional 225,826 shares in the last quarter. Bank of The West boosted its stake in Cardinal Health by 9.3% in the third quarter. Bank of The West now owns 34,794 shares of the company’s stock valued at $2,703,000 after buying an additional 2,974 shares in the last quarter. Finally, Cooke & Bieler LP boosted its stake in Cardinal Health by 1.2% in the third quarter. Cooke & Bieler LP now owns 1,218,833 shares of the company’s stock valued at $94,704,000 after buying an additional 13,962 shares in the last quarter. Hedge funds and other institutional investors own 85.84% of the company’s stock.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.